ABSTRACT. Binding of secretory IgA (sIgA) to human milk macrophages was identified by rosette formation with sIgA-sensitized indicator cells and competitive inhibition binding studies with P 25 I)_sIgA. Macrophages formed rosettes with sIgA-sensitized sheep red blood cells that were inhibited by sIgA (87%) but not IgG. Both IgA) and IgA 2 inhibited sIgA-sensitized sheep red blood cell rosette formation. Rosette formation was completely inhibited by galactose, partially inhibited by asialofetuin, and unaffected by mannose. ( J25I)-labeled sIgA binding to macrophages reached a plateau after 60 min, was dependent on the number of macrophages in culture, and was specifically inhibited by unlabeled sIgA. Incubation of macrophage monolayers with increasing concentrations of sIgA-antiIgA immune complexes resulted in a progressive increase in the oxidative burst and increased secretion of prostaglandins. These studies indicate that human milk macrophages have a receptor for sIgA and that activation of these macrophages may occur via these receptors. (Pediatr Res 29: 429-434, 1991) 
may act synergistically with C 3 and lysozyme (6) and lactoferrin (7) to inhibit growth or kill bacteria. Antibodies of the IgAisotype to attenuated poliovirus (8) , rotavirus (9) , respiratory syncytial virus (10) , and Vibrio cholerae (11) are known to protect against their pathogenicity. Recently, an IgA-lgG preparation has been shown to prevent necrotizing enterocolitis in low birth weight infants (12) .
The HMM are the predominant leukocytes present in human milk (13) . They are capable of phagocytosis and killing of bacteria and fungi (14) , and they produce lysozyme and prostaglandins (15) , modulate lymphocyte reactivity (16) , and protect against experimental necrotizing enterocolitis (17). Intracellular IgA is present within these macrophages (18, 19) . Its function has not been determined and the process by which it is internalized has not been examined, although mechanisms for its release have been postulated (20) . We have previously shown that a receptor for lactoferrin is present on the HMM, thus suggesting an interaction between the aqueous and cellular phases of human milk (21) . The aim of this study was to identify a receptor for sIgA on the HMM cell membrane and to show that cellular processes may be mediated through this receptor.
MATERIALS AND METHODS
Human milk was expressed by sterile technique from nursing mothers from 2 to 7 d postpartum. It was kept at room temperature in a sterile container and cultured within 1 h.
Macrophages. Milk (7.5 mL) was layered onto 2.5 mL of Ficoll Hypaque and centrifuged for 25 min at 400 x g. The fat layer was removed and the mononuclear cell layer was washed three times in PBS and resuspended at a concentration of I x 10 6 cells/ml. in RPM I supplemented with penicillin (100 U/mL), streptomycin (100 ,ug/mL), and 10% heat-inactivated, milliporefiltered FCS (complete medium). Of this cell suspension, 0.5 mL was pipetted into 16-mm diameter wells of tissue culture plates (Limbro Chemical Co., Newhaven, CT) for prostaglandin assays and 0.1 mL into 8-mm diameter wells (96-well microtitre plates; Falcon, Oxnard, CA) for hydrogen peroxide assays. The cells were rocked gently for 45 min to facilitate adherence and washed to remove nonadherent cells. The resultant macrophage monolayers were cultured in complete medium at 37"Cin a humidified atmosphere of 5% CO2in air. These cells were viable, inasmuch as more than 90% excluded trypan blue. They showed characteristics of macrophages in that they stained positive with nonspecific esterase and large endocytic vacuoles were shown to contain lipid with a Sudan III stain. They phagocytized latex and zymosan particles and evidence of a C3 receptor was shown by binding of zymosan particles that had activated complement (15) .
The followingchemical reagents were purchased: Human sIgA, human colostrum by ammonium sulphate precipitation and diethylaminoethyl chromatography was bound to chromiumtreated SRBC as previously described (22) . Control SRBC were treated with chromium chloride alone. The sIgA preparation was verified to be more than 98% pure by SDS-PAGE, and neither IgG nor IgM were detected by ELISA. The concentration used was the lowest concentration required to result in agglutination ofE-sIgA when tested with anti-IgA antibody.
Rosettes were formed by mixing equal volumes of macrophages at I X 10 6 / mL with 1% E-sIgA. The mixtures were 6 HMM/mL in RPM I and 10% FCS (l mL volume) were incubated with 0.1 mL [ l25I]-labeled sIgAdiluted I: 100 in normal saline at 4°C. At varying intervals, the cells were separated by centrifugation at 600 x g for 10 min. The supernatants were decanted and the cell pellets washed twice with PBS. The washes were added to the supernatants. Parallel incubations were performed with cell-free tubes to correct for nonspecific binding of [ 125I]-labeled sIgA to the test tube. The radioactivity of the samples was counted in a gamma counter. All samples were tested in duplicate.
Competitive inhibition of [ 125I]-labeled sIgA binding to HMM was tested by prior incubation with increasing concentrations of unlabeled sIgA added to the cell suspension at 4°C. After 1 h, cells were separated and washed, and radioactivity was measured as described above.
To demonstrate that binding of the labeled ligand depended on the number of cells used, increasing numbers of HMM in a constant volume of 1 mL of complete medium were incubated with a constant amount of radiolabeled ligand (0.1 mL of [ 1251]_ labeled sIgA in a 1:1000 dilution). After incubation at 4°C for 1 h, the cells were separated and washed, and radioactivity was measured as previously described.
Hydrogen peroxide assay. HMM monolayers in 96-well flat bottom trays were incubated in the presence of varying concentrations of either sIgA alone or complexes formed in situ by addition of sIgA and anti-IgA. To confirm that macrophage activation had not occurred through the Fe receptor of the antiIgA molecule, which is of the IgG isotype, these experiments were done with the F(ab')2 portion of the antibody. Controls included macrophages incubated with sIgA and anti-IgA antibody alone and phorbol myristate acetate (20 nM). This microassay was performed as described by Pick and Keisary (24) . Briefly, the HMM cultures were incubated for 60 min in the presence of a phenol red solution that contained 140 mM NaCl, 10 mM potassium phosphate buffer, pH 7.0, 5.5 mM dextrose, 0.56 mM phenol red, and 19 U/ml. of horseradish peroxidase. The reaction was stopped with 10 JiL of IN NaOH per well and the 00 of each sample was determined by a micro-ELISA reader (model MR580; Oynatech Laboratories, Alexandria, VA) fitted with wavelength filter of 600 nm.
Prostaglandin assay. HMM in 16-mm diameter wells were incubated with varying concentrations of sIgA-anti-IgA complexes for 48 h. Macrophages without any added stimuli, or with addition of concanavalin A (20 Jig/mL) (Sigma Chemical Co.), sIgA, or anti-IgA alone served as controls. The supernatants were removed and stored at -20°C until assayed. PGE2 was isolated from the extracellular medium by ethanol extraction. After evaporation, the residue was redissolved in methanol and the sample assayed in a high pressure liquid chromatography system as described previously (25) . Appropriate internal standards of PGE 2 were run in parallel with samples tested. Each sample was tested in duplicate.
Statistical analysis. The results are expressed in the figures and tables as mean ± SO. Significant effect of addition of IgA, IgAanti-IgA immune complexes in comparison to control culture was tested by t test.
RESULTS
Rosette assay. Forty-five ± 4% of HMM in culture formed rosettes with E-sIgA. Incubation with unsensitized SRBC showed rosette formation with 7 ± 3% HMM. Rosette formation was inhibited by prior incubation with sIgA but not IgG (Fig. I) Rosette formation was also inhibited by galactose, partially inhibited by asialofetuin, and not affected by mannose ( Both 19A, and 19A2 resulted in inhibition of E-slgA rosette formation by HMM ( Table 2) . Binding assay. Binding of sIgA to HMM was time-dependent, reaching a plateau after 60 min (Fig. 2) . This binding was also dependent on the number of macro phages present in culture (Fig. 3) . Binding of the labeled ligand was shown to be specific, inasmuch as increasing concentrations of unlabeled sIgA inhibited binding of tracer amounts of [ 125I]-labeled sIgA (Fig. 4) .
HzO z assay. Incubation of HMM monolayers with sIgA immune complexes resulted in increased macrophage H 202 production. This effect was achieved with both whole antibody and the F(ab'h antibody, excluding the possibility that these cells were activated via an IgG receptor; sIgA alone showed only a slight increase in comparison with untreated cells. The increase in H 202 was dependent upon the concentration of sIgA added, and was therefore probably related to the number of complexes formed in situ in the monolayer. Addition of anit-IgA antibody alone did not result in increased H 202 production (Fig. 5) .
PGE z assay. As expected, addition of concanavalin A induced secretion of PGE 2 into the HMM extracellular medium and served as a positive control. Exposure of the HMM to increasing concentration of sIgA-anti-IgA complexes formed in situ induced secretion ofPGE 2 by these cells in culture. Neither sIgA nor antiIgA alone induced an elevated secretion of PGE 2 products compared with untreated cells. (Fig. 6) . DISCUSSION We studied the characteristics and specificity of binding of sIgA to the HMM cell membrane. We have demonstrated that the HMM cell membrane can specifically bind sIgA. This was shown by specific inhibition of rosette formation with E-sIgA by prior incubation with sIgA but not IgG. Binding of [ 125I]-labeled sIgA was shown to be time-dependent and dependent on the number of cells present in culture, and could be specifically inhibited by prior incubation with unlabeled sIgA.
The presence ofspecific IgA Fe receptors on human peripheral blood monocytes and animal macrophages has been reported using varied techniques of identification of ligand binding to the receptor (26) (27) (28) (29) (30) . We and others have shown a higher percentage of rosette formation (70% of peripheral blood monocytes) using similar techniques (31) . It is possible in particular in HMM that residual sIgA from the aqueous phase of breast milk on the plasma membrane may account for the relatively low percentage of macro phages that we found to form E-sIgA rosettes.
IgA may bind to cell membranes by one of three described processes. FcaR are present on the plasma membrane of human polymorphonuclear cells and monocytes (26, 27) . The secretory component has been identified as a polymeric IgA receptor on hepatocytes (32) and the ASG receptor has been shown to bind IgAl (33) . The clearance of IgA by the rat hepatocyte has been shown to be mediated by both the secretory component and the ASG receptor (34) . Recent studies of the molecular nature of the IgA receptor on human phagocytes have shown that it is distinct from ASG or polymeric IgA receptors (28) . A 60-kD FeaR molecule distinct from each of the three Fc)'R molecules on human phagocytes that binds both monomeric and polymeric IgA, and IgAz has been identified (35) . These studies have not as yet been extended to the characterization of the IgA receptor on the HMM. In our studies, sIgA inhibited E-sIgA rosette formation and both IgAl and IgA2 resulted in dose-dependent inhibi- tion even when used at much lower concentrations. In addition, varying degrees of inhibition of rosette formation with galactose and asialofetuin, but not with man nose, were noted. Breast milk contains both IgA, and IgAz proteins (36) , and inhibition of rosette formation by both IgA subclasses implicates the FcaR in sIgA binding to the HMM plasma membrane. The structural difference between IgA, and IgAz is at the hinge region, where IgAz molecules have a 13-amino acid sequence deletion that includes five galactosamine oligosaccharides compared with IgA, (37) . Therefore, the inhibition ofE-sIgA rosette formation demonstrated with both galactose and asialofetuin suggests that the binding to the HMM receptor occurs via similar interactions, at least for the binding of IgA,. Similar results have been reported in studying the binding of IgA, to rat peritoneal macrophages and the hepatic receptor for asialoglycoprotein (29, 38) . Although we have shown that specific binding of sIgA occurs to the HMM plasma membrane, we have not been able to conclusively define the molecular nature of this receptor.
The induction of the oxidative burst by sIgA-anti-IgA complexes is in accordance with the results of Gorter et al. (39) , who induced the oxidative burst in human peripheral blood monocytes by IgA-and sIgA-opsonized Staphylococcus aureus, and Fanger et al. (30) , who showed that oral leukocytes were capable of phagocytosis of erythrocytes opsonized with rabbit sIgA. It is likely that colostral sIgA acts as an opsonin in the neonatal gastrointestinal tract and its ingestion and presence inside the HMM may be responsible for induction of the oxidative burst.
The HMM has been shown to be a source of prostaglandins present in human milk. PGEz, which is present in largequantities in human milk, has numerous effects on the gastrointestinal tract, including gastrointestinal cytoprotection (40) , promotion of intestinal mucosal and cellular integrity (41) , and the ability to increase intestinal motility (42) and release brush border enzymes (43) . Our experiments showed that sIgA-anti-IgA complexes were able to induce secretion of PGEz from the HMM, thus implying that this mediator may have a local protective role on the developing neonatal gastrointestinal tract.
The wider clinical significance of our findings is still to be determined. In addition to a major role in the human milk immunologic system and its local protective effect, the sIgAmacrophage interaction may also exert influence on other systems that play an as yet undetermined role in the developing neonatal gastrointestinal tract (44) .
